Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial)

https://doi.org/10.1016/0002-9149(89)91037-0Get rights and content

Abstract

To evaluate the different contributions of infarct site and infarct extent in determining the in-hospital outcome and efficacy of thrombolytic therapy, 8,731 patients with a first Q-wave acute myocardial infarction (AMI) enrolled in the GISSI trial were studied. On the basis of the standard 12-lead electrocardiogram, the sample was classified in 2 ways: classic electrocardiographic site pattern (anterior, inferior, lateral and multiple location), and number of standard electrocardiographic leads with ischemic ST elevation (small, modest, large and extensive infarct in 2 to 9 leads). In-hospital mortality was evaluated according to infarct site, infarct extent and fibrinolytic treatment. The mortality rate was differently distributed in the various infarct sites. Streptokinase significantly reduced mortality only in anterior (13.8 vs 18.7%) and multiple site infarcts (8.1 vs 12.5%). According to the infarct extent observed, there is a progressive increase in the mortality rate—from 6.5% in small infarcts to 9.6% in modest, 14.3% in large and 21.7% in extensive. No significant benefit was obtained by streptokinase in small infarcts; in contrast, a significant decrease in mortality was achieved in modest (7.7 vs 11.4%), large (12.8 vs 16.6%) and extensive infarcts (19.5 vs 23.9%). Thus, the extent of myocardial injury seems to be more relevant than the site in determining in-hospital mortality and efficacy of thrombolytic therapy.

References (22)

  • R.M. Norris et al.

    Prognosis after myocardial infarction. Six year follow-up

    Br Heart J

    (1974)
  • Cited by (98)

    • Ventricular arrhythmias are associated with increased QT interval and QRS dispersion in patients with ST-elevation myocardial infarction

      2022, Revista Portuguesa de Cardiologia
      Citation Excerpt :

      Hathaway et al.37 found that the sum of the absolute ST deviation greater than 19 mm and QRS duration greater than 100 ms were strong predictors of 30-day mortality (OR 1.53; 95% CI 1.38-1.69). Mauri et al.38 also described a relationship between the number of involved leads and worse prognosis. In our series mortality was higher in patients who presented VA.

    • ST-segment elevation myocardial infarction

      2012, Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease: Fourth Edition
    • Acute Coronary Syndromes and Acute Myocardial Infarction

      2008, Critical Care Medicine: Principles of Diagnosis and Management in the Adult
    • ST-Elevation Myocardial Infarction

      2007, Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease
    View all citing articles on Scopus
    View full text